SagiPlan 2.2, CE0344
Recall Z-0517-2024, part of FDA recall event 93399. See Bebig Isotopentechnik's company page.
Bebig Isotopentechnik Gmbh started this Class II device recall on Oct 17, 2023 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Oct 17, 2023
- Status: Ongoing
Due to software malfunction, numerical values may be rounded resulting in inaccurate measurements.
- Product
- SagiPlan 2.2, CE0344, Rx Only , Brachyterapy Treatment Planning System
- Quantity
- 2 software licenses in US, 255 software licenses in OUS
- Lots and codes
- SagiPlan, article # 1374-0600, version 2.2
- Distribution
- US: MD OUS: Germany
- Recalling firm
- Bebig Isotopentechnik Gmbh, Berlin, N/A, Germany
- How the firm notified
- Letter
- FDA classified
- Dec 8, 2023
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports